These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25033460)

  • 1. A multiscale approach to modelling drug metabolism by membrane-bound cytochrome P450 enzymes.
    Lonsdale R; Rouse SL; Sansom MS; Mulholland AJ
    PLoS Comput Biol; 2014 Jul; 10(7):e1003714. PubMed ID: 25033460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane-embedded substrate recognition by cytochrome P450 3A4.
    Hackett JC
    J Biol Chem; 2018 Mar; 293(11):4037-4046. PubMed ID: 29382727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flexibility of human cytochrome P450 enzymes: molecular dynamics and spectroscopy reveal important function-related variations.
    Hendrychová T; Anzenbacherová E; Hudeček J; Skopalík J; Lange R; Hildebrandt P; Otyepka M; Anzenbacher P
    Biochim Biophys Acta; 2011 Jan; 1814(1):58-68. PubMed ID: 20656072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cholesterol on the structure of membrane-attached cytochrome P450 3A4.
    Navrátilová V; Paloncýová M; Kajšová M; Berka K; Otyepka M
    J Chem Inf Model; 2015 Mar; 55(3):628-35. PubMed ID: 25654496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing the membrane-bound state of cytochrome P450 3A4: structure, depth of insertion, and orientation.
    Baylon JL; Lenov IL; Sligar SG; Tajkhorshid E
    J Am Chem Soc; 2013 Jun; 135(23):8542-51. PubMed ID: 23697766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450-The Wonderful Nanomachine Revealed through Dynamic Simulations of the Catalytic Cycle.
    Dubey KD; Shaik S
    Acc Chem Res; 2019 Feb; 52(2):389-399. PubMed ID: 30633519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding a substrate's product regioselectivity in a family of enzymes: a case study of acetaminophen binding in cytochrome P450s.
    Yang Y; Wong SE; Lightstone FC
    PLoS One; 2014; 9(2):e87058. PubMed ID: 24498291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved cytochrome P450 3A4 molecular models accurately predict the Phe215 requirement for raloxifene dehydrogenation selectivity.
    Moore CD; Shahrokh K; Sontum SF; Cheatham TE; Yost GS
    Biochemistry; 2010 Oct; 49(41):9011-9. PubMed ID: 20812728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural differences between soluble and membrane bound cytochrome P450s.
    Denisov IG; Shih AY; Sligar SG
    J Inorg Biochem; 2012 Mar; 108():150-8. PubMed ID: 22244217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and dynamics of the membrane-bound cytochrome P450 2C9.
    Cojocaru V; Balali-Mood K; Sansom MS; Wade RC
    PLoS Comput Biol; 2011 Aug; 7(8):e1002152. PubMed ID: 21852944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioengineering of Cytochrome P450 OleT
    Reinhard FGC; Lin YT; Stańczak A; de Visser SP
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32526971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theoretical characterization of substrate access/exit channels in the human cytochrome P450 3A4 enzyme: involvement of phenylalanine residues in the gating mechanism.
    Fishelovitch D; Shaik S; Wolfson HJ; Nussinov R
    J Phys Chem B; 2009 Oct; 113(39):13018-25. PubMed ID: 19728720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent cooperativity and substrate inhibition in the epoxidation of carbamazepine by cytochrome P450 3A4 active site mutants inspired by molecular dynamics simulations.
    Müller CS; Knehans T; Davydov DR; Bounds PL; von Mandach U; Halpert JR; Caflisch A; Koppenol WH
    Biochemistry; 2015 Jan; 54(3):711-21. PubMed ID: 25545162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational dynamics of CYP3A4 demonstrate the important role of Arg212 coupled with the opening of ingress, egress and solvent channels to dehydrogenation of 4-hydroxy-tamoxifen.
    Shahrokh K; Cheatham TE; Yost GS
    Biochim Biophys Acta; 2012 Oct; 1820(10):1605-17. PubMed ID: 22677141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What Your Crystal Structure Will Not Tell You about Enzyme Function.
    Pochapsky TC; Pochapsky SS
    Acc Chem Res; 2019 May; 52(5):1409-1418. PubMed ID: 31034199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytochrome P450 enzymes bind drugs and other substrates mainly through conformational-selection modes.
    Guengerich FP; Wilkey CJ; Phan TTN
    J Biol Chem; 2019 Jul; 294(28):10928-10941. PubMed ID: 31147443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying cytochrome p450 functional networks and their allosteric regulatory elements.
    Liu J; Tawa GJ; Wallqvist A
    PLoS One; 2013; 8(12):e81980. PubMed ID: 24312617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How does the reductase help to regulate the catalytic cycle of cytochrome P450 3A4 using the conserved water channel?
    Fishelovitch D; Shaik S; Wolfson HJ; Nussinov R
    J Phys Chem B; 2010 May; 114(17):5964-70. PubMed ID: 20387782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane-Anchored Cytochrome P450 1A2-Cytochrome b5 Complex Features an X-Shaped Contact between Antiparallel Transmembrane Helices.
    Jeřábek P; Florián J; Martínek V
    Chem Res Toxicol; 2016 Apr; 29(4):626-36. PubMed ID: 26918755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QM/MM modelling of drug-metabolizing enzymes.
    Lonsdale R; Mulholland AJ
    Curr Top Med Chem; 2014; 14(11):1339-47. PubMed ID: 24805066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.